Challenges in palliative care research; recruitment, attrition and compliance: Experience from a randomized controlled trial

Palliative Medicine

Volumn 13, Issue 4, 1999, Pages 299-310

  Jordhoy M S ^a   Kaasa, S ^a   Fayers, P ^c   OVreness T ^b   Underland, G ^b   Ahlner Elmqvist, M ^c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NONE

Author keywords

Clinical trials; Neoplasms; Palliative care; Quality of life; Research

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL RESEARCH; DEATH; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METHODOLOGY; PALLIATIVE THERAPY; PATIENT COMPLIANCE; PATIENT REFERRAL; PATIENT SELECTION; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; PATIENT COMPLIANCE; PATIENT SELECTION; QUALITY OF LIFE; RESEARCH DESIGN;

EID: 0032784936     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/026921699668963873     Document Type: Article

References (61)

1. Rinck GC, Van den Bos GAM, Kleijnen J, de Haes HJCJM, Schade E, Veenhof CHN. Methodological issues in effectiveness research on palliative cancer care: A systematic review. J Clin Oncol 1997; 15: 1697-1707.
2. McWhinney IR, Bass MJ, Donner A. Evaluation of a palliative care service: problems and pitfalls. Br Med J 1994; 309: 1340-42.
3. Rinck GC, Kleijnen J, Van den Bos GAM, de Haas HCJM, Schade E, Veenhof CHN. Trials in palliative care [letter]. Br Med J 1995; 310: 598-99.
4. Mor V, Stalker MZ, Gralla R et al. Day hospital as an alternative to inpatient care for cancer patients: a random assignment trial. J Clin Epidemiol 1988; 41: 771-85.
5. McCorkle R, Benoliel JQ, Donaldson G, Georgiadou F, Moinpour C, Godell B. A randomized clinical trial of home nursing care for lung cancer patients. Cancer 1989; 64: 1375-82.
6. Addington-Hall JM, MacDonald LD, Anderson HR et al. Randomised controlled trial of effects of coordinating care for terminally ill cancer patients. Br Med J 1992; 305: 1317-22.
7. Kane RL, Bernstein L, Wales J, Leibowitz A, Kaplan S. A randomised controlled trial of hospice care. Lancet 1984; 1: 890-94.
8. Zimmer JG, Groth-Junker A, McCusker J. A randomized controlled study of a home health care team. Am J Public Health 1985; 75: 134-41.
9. Hughes SL, Cummings J, Weaver F, Manheim L, Braun B, Conrad K. A randomized trial of the cost effectiveness of VA hospital-based home care for the terminally ill. Health Serv Res 1992; 26: 801-17.
10. Weissert WG, Wan TTH, Livieratos BB, Pellegrino J. Cost-effectiveness of homemaker services for the chronically ill. Inquiry 1980; 17: 230-43.
11. Toseland RW, Blanchard CG, McCallion P. A problem solving intervention for caregivers of cancer patients. Soc Sci Med 1995; 40: 517-28.
12. Dodd MJ. Efficacy of proactive information on self-care in chemotherapy patients. Patient Edu Couns 1988; 11: 215-25.
13. Gotay CC. Accrual to cancer clinical trials: direction from the research literature. Soc Sci Med 1991; 33: 569-77.
14. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials 1987; 8: 6S-30S.
15. Lovato LC, Hill K, Herert S, Hunninghake DB, Probstfield JL. Recruitment for controlled clinical trials: literature summary and annotated bibliography. Control Clin Trials 1997; 18: 328-57.
16. Ling J, Hardy J, Penn K, Davis C. Evaluation of palliative care. Recruitment figures may be low [letter]. Br Med J 1995; 310: 125.
17. Hopwood P, Stephens RJ, Machin D for the MRC Lung Cancer Working Party. Approaches to the analyses of quality of life data: experience gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial. Qual Life Res 1994; 3: 339-52.
18. Medical Research Council Lung Cancer Working Party. A randomised trial of three or six courses of etoposide, cyclophosphamide, methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: quality of life. Br J Cancer 1993; 68: 1157-66.
19. Fayers PM, Bleehen NM, Girling DJ, Stephens RJ. Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party. Br J Cancer 1991; 64: 299-306.
20. Kaasa S, Mastekaasa A, Naess S. Quality of life of lung cancer patients in a randomized clinical trial evaluated by a psychosocial well-being questionnaire. Acta Oncol 1988; 27: 335-42.
21. Kaasa S, Hjermstad MJ, Jordhøy MS, Wisløff F, Loge JH. Compliance in quality of life data: a Norwegian experience. Stat Med 1998; 17: 623-32.
22. Donelly S, Walsh D. Quality of life assessment in advanced cancer. Pall Med 1996; 10: 275-83.
23. Omsorg og kunnskap. Norsk kreftplan. Oslo: Statens forvaltningstjeneste. Statens trykning, NOU 1997; 20: 44, 89.
24. Forekomst av kreftsykdommer i Norges kommuner. Antall nye tilfelle i 1982-1991. Antall personer med tidligere kreftdiagnose i live pr 1/1-92. Oslo, Norway: Institute of Epidemiological Cancer Research. Norwegian Cancer Registry, 1993.
25. Aaronson NK, Ahmedzai SA, Bergman B. The EORTC QLQ-C30: A quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
26. Kaasa S, Bjordal K, Aaronson N et al. and the EORTC Study Group on Quality of Life. The EORTC Core Quality of Life Questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 1995; 31A: 2260-63.
27. Horowitz MJ, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979; 41: 209-18.
28. Kaasa S, Malt U, Hagen S, Wist E, Moum T, Kvikstad A. Psychological distress in cancer patients with advanced disease. Radiother Oncol 1993; 27: 193-97.
29. MacAdam DB. An initial assessment of suffering in terminal illness. Palliat Med 1987; 1: 37-47.
30. Fowlie M, Berkeley J, Dingwall-Fordyce I. Quality of life in advanced cancer: the benefits of asking the patient. Palliat Med 1989; 3: 55-59.
31. Holmen J, Midthjell K, Bjartveit K et al. The North-Troendelag Health Survey 1984-1986. Purpose background and methods. Participation, nonparticipation and frequency distributions. National Institute of Public Health, Unit of Health Service Research, Oslo, Norway; National Institute of Public Health, Community Medicine Research Centre, Verdal Norway, Report 4, 1990.
32. Paloutzian RF, Ellison C. Loneliness, spiritual well-being and the quality of life. In: Peplau LA, Perlman D eds. Loneliness: a sourcebook of current theory, research, and therapy. New York: Wiley Interscience, 1982: 224-37.
33. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
34. Cohen J. Statistical power analysis for the behavioral sciences, 2nd edn. Hillsdale, NJ: Laurence Erlbaum, 1988.
35. Machin D, Campbell MJ, Fayers PM, Pinol A. Sample size tables for clinical studies, 2nd edn. Oxford: Blackwell Science, 1997.
36. Bradford RH. Participant recruitment to the Lipid Research Clinics Coronary Primary Prevention Trial. Control Clin Trials 1987; 8: 31S-40S.
37. Hollis JF, Satterfield S, Smith F et al. on behalf of the Trials of Hypertension Prevention (TOPH) Collaborative Research Group. Recruitment of phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Ann Epidemiol 1995; 5: 140-48.
38. Schoenberger JA. Recruitment experience in the Aspirin Myocardial Infarction Study. Control Clin Trials 1987; 8: 74S-78S.
39. Eaton T, Pratt CM. A clinic's perspective on screening, recruitment and data collection. Stat Med 1990; 9: 137-43.
40. Brown JM, Haining SA, Hale JM. Views on local data management in cancer clinical trials. Clin Oncol (R Coll Radiol) 1997; 9: 403-406.
41. Milgrom PM, Hujoel PP, Weinstein P, Holborow DW. Subject recruitment, retention, and compliance in clinical trials in periodontics. Ann Periodontol 1997; 2: 64-74.
42. Adams J, Silverman M, Musa D, Peele P. Recruiting older adults for clinical trials. Control Clin Trials 1997; 18: 14-26.
43. Kottke TE, Solberg LI, Conn S et al. A comparison of two methods to recruit physicians to deliver smoking cessation interventions. Arch Intern Med 1990; 150: 1477-81.
44. Taylor KM, Margolese RG, Soskolne CL. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med 1984; 10: 363-67.
45. Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D, Stephens R on behalf of the MRC Cancer Trials Office. Quality of life assessment in clinical trials. Guidelines and a checklist for protocol writers: the U.K. Medical Research Council Experience. Eur J Cancer 1997; 33: 20-28.
46. Parkes CM. Accuracy of predictions of survival in later stages of cancer. Br Med J 1972; 2: 29-31.
47. Forster LE, Lynn J. Predicting life span for applicants to inpatients hospice. Arch Intern Med 1988; 148: 2540-43.
48. Heyse-Moore LH, Johnson-Bell VE. Can doctors accurately predict the life expectancies of patients with terminal cancer? Palliat Med 1987; 1: 165-66.
49. den Daas N. Estimating length of survival in end-stage cancer: a review of the literature. J Pain Symptom Manage 1995; 10: 548-55.
50. Allard P, Dionne A, Potvin D. Factors associated with length of survival among 1081 terminally ill cancer patients. J Palliat Care 1995; 11(3): 20-24.
51. Maltoni M, Pirovano M, Scarpi E et al. Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study. Cancer 1995; 75: 2613-22.
52. Maltoni M, Pirovano M, Nanni O et al. Biological indices predictive of survival in 519 Italian terminally ill cancer patients. J Pain Symptom Manage 1997; 13: 1-9.
53. Wisløff F, Hjorth M. Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group. Br J Haematol 1997; 97: 29-37.
54. Kaasa S, Mastekaasa A, Lund E. Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. Radiother Oncol 1989; 15: 235-42.
55. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 1980; 45: 2220-24.
56. Hickey AM, Bury G, O'Boyle CA, Bradley F, O'Kelly FD, Shannon W. A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. Br Med J 1996; 313: 29-33.
57. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient? Br J Cancer 1988; 57: 109-12.
58. Rothman ML, Hedrick SC, Bulcroft KA, Hickam DH, Rubenstein LZ. The validity of proxygenerated scores as measures of patient health status. Med Care 1991; 29: 115-24.
59. Bjordal K, Freng A, Thorvik J, Kaasa S. Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study. Eur J Cancer B Oral Oncol 1995; 31B: 235-41.
60. Blazeby JM, Williams MH, Alderson D, Farndon JR. Observer variation in assessment of quality of life in patients with oesohageal cancer. Br J Surg 1995; 82: 1200-203.
61. Sneeuw KCA, Aaronson NK, Sprangers MAG, Detmar SB, Wever LDV, Schornagel JH. Value of caregiver ratings in evaluating the quality of life of patients with cancer. J Clin Oncol 1997; 15: 1206-17.